BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31023379)

  • 1. Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis.
    Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
    Acta Neuropathol Commun; 2019 Apr; 7(1):58. PubMed ID: 31023379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis.
    Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
    Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.
    Elkjaer ML; Hartebrodt A; Oubounyt M; Weber A; Vitved L; Reynolds R; Thomassen M; Rottger R; Baumbach J; Illes Z
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200213. PubMed ID: 38564686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.
    Frisch T; Elkjaer ML; Reynolds R; Michel TM; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
    Netw Syst Med; 2020; 3(1):122-129. PubMed ID: 32954379
    [No Abstract]   [Full Text] [Related]  

  • 5. Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain.
    Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F; Agresti C
    Front Cell Neurosci; 2020; 14():190. PubMed ID: 32733206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.
    Zeis T; Howell OW; Reynolds R; Schaeren-Wiemers N
    Exp Neurol; 2018 Jul; 305():76-88. PubMed ID: 29596844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signature of slowly expanding lesions in progressive multiple sclerosis.
    Jäckle K; Zeis T; Schaeren-Wiemers N; Junker A; van der Meer F; Kramann N; Stadelmann C; Brück W
    Brain; 2020 Jul; 143(7):2073-2088. PubMed ID: 32577755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?
    Boscia F; Elkjaer ML; Illes Z; Kukley M
    Front Cell Neurosci; 2021; 15():685703. PubMed ID: 34276310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Bruton´s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination.
    Elkjaer ML; Waede MR; Kingo C; Damsbo K; Illes Z
    Front Immunol; 2023; 14():1264128. PubMed ID: 38022591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
    De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia and astroglia proliferation within the normal appearing white matter in histologically active and inactive multiple sclerosis.
    Nowacki P; Koziarska D; Masztalewicz M
    Folia Neuropathol; 2019; 57(3):249-257. PubMed ID: 31588711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
    Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
    Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis.
    Ahmad I; Wergeland S; Oveland E; Bø L
    ASN Neuro; 2023; 15():17590914231198980. PubMed ID: 38062768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
    Mohan H; Friese A; Albrecht S; Krumbholz M; Elliott CL; Arthur A; Menon R; Farina C; Junker A; Stadelmann C; Barnett SC; Huitinga I; Wekerle H; Hohlfeld R; Lassmann H; Kuhlmann T; Linington C; Meinl E
    Acta Neuropathol Commun; 2014 Dec; 2():168. PubMed ID: 25589163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
    Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
    Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study.
    Vercellino M; Trebini C; Capello E; Mancardi GL; Giordana MT; Cavalla P
    J Neuroimmunol; 2017 Nov; 312():49-58. PubMed ID: 28919237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS.
    Pardini M; Petracca M; Harel A; Fleysher L; Oesingmann N; Bommarito G; Fabian M; Chard D; Lublin F; Inglese M
    Neuroimage Clin; 2017; 16():111-115. PubMed ID: 28794971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.